FMR LLC 13D and 13G filings for Candel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 10:18 am Purchase | 2025-01-31 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 6,318,721 15.000% | 2,395,122 (+61.04%) | Filing |
| 2025-02-07 10:03 am Purchase | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 3,923,599 9.300% | 3,186,003 (+431.94%) | Filing |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 737,596 2.552% | -1,525,246 (-67.40%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Candel Therapeutics, Inc. CADL | FMR LLC | 2,262,842 7.887% | 2,262,842 (New Position) | Filing |